miRNA在前列腺癌中的研究进展
摘要
关键词
全文:
PDF (English)参考
Siegel RL, Miller KD, Jemal A, et al. Cancer statistics[J]. CA Cancer J Clin, 2019(01):7-37.
Chitwood DH, Timmermans MCP. Small RNAs are on the move[J]. Nature, 2010(7314):415-419.
Bohnsack MT. Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs[J]. RNA, 2004(02):185-191.
Asada K, Kobayashi K, Joutard S, et al. Uncovering prognosis-related genes and pathways by Multi-Omics analysis in lung cancer[J]. Biomolecules, 2020(04):524.
Dall'Era, MA. Active surveillance for early-stage prostate cancer[J]. Cancer, 2008(08):1650-1659.
Tutar Y. miRNA and cancer. Computational and experimental approaches[J]. Curr Pharm Biotechnol, 2014(05):429.
Suer I, Guzel E, Karatas OF, et al. MicroRNAs as prognostic markers in prostate cancer[J]. The Prostate, 2018(03):265-271.
Brown J A, Bourke E. Practical bioinformatics analysis of miRNA data using online tools[J]. Methods Mol Biol, 2017(09):195-208.
Chen, J, Xu LF, Hu HL, et al. MiRNA-215-5p alleviates the metastasis of prostate cancer by targeting PGK1[J]. European review for medical and pharmacological sciences, 2020(02): 639.
Wang J, Ni J, Beretov J, et al. Exosomal microRNAs as liquid biopsy biomarkers in prostate cancer[J].Crit. Rev Oncol Hematol, 2020(05):102860.
Stuopelyte K, Daniunaite K, Bakavicius A, et al., The utility of urine-circulating miRNAs for detection of prostate cancer[J]. British Journal of Cancer, 2016(06): 707-715.
Zedan AH, Osther PJS,Assenholt J, et al.Circulating miR-141 and miR-375 are associated with treatment outcome in metastatic castration resistant prostate cancer[J]. Scientific Reports, 2020(01):227.
DOI: http://dx.doi.org/10.26549/yzlcyxzz.v3i8.6248
Refbacks
- 当前没有refback。
此作品已接受知识共享署名-非商业性使用 4.0国际许可协议的许可。